Annamycin is currently being evaluated in continuing clinical trials for the treatment of relapsed or refractory acute myeloid leukemia and soft tissue sarcoma lung metastases. Annamycin has fast ...
September is Childhood Cancer Awareness Month. The most common type of childhood cancer is acute lymphocytic leukemia (ALL), ...
Sutro Biopharma specializes in ADCs for oncology and shows promise with STRO-002 for ovarian cancer and collaborations with ...
Annamycin is currently being evaluated in continuing clinical trials for the treatment of relapsed or refractory acute myeloid leukemia and soft tissue sarcoma lung metastases. Annamycin has Fast ...
The observed organotropic properties of Annamycin, its efficacy in vivo, and its promising safety profile warrant further translational studies to evaluate Annamycin in patients with primary or ...
ImpriMed Unveils Cancer Treatment Prediction Technology at EHA-SfPM Meeting, Expands AI-Driven Precision Medicine Services ...
GlobalData on MSN5h
Actinium Pharmaceuticals reports data from Phase III trial of AML treatmentActinium Pharmaceuticals has reported data from the Phase III SIERRA clinical trial of Iomab-B (Iodine-131-apamistamab) to treat patients with relapsed or refractory acute myeloid leukaemia (r/r AML).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback